Attached are comments from 8 health and fair groups regarding a prospective grant of an exclusive license to NIH owned patent, for the development of an Anti-Mesothelin Chimeric Antigen Receptor (CAR) for the treatment of human Cancer, to Atara Biotherapeutics Inc.
Atara-Biotherapeutics-NGO-Comments2NIH-13Jul2018
The eight groups signing the comments were:
- Health Action International (HAI)
- Health GAP
- Interfaith Center on Corporate Responsibility (ICCR)
- Knowledge Ecology International (KEI)
- People of Faith for Access to Medicines (PFAM)
- Social Security Works (SSW)
- Union for Affordable Cancer Treatment (UACT)
- Universities Allied for Essential Medicines (UAEM)